Adverum Biotechnologies Q4 Earnings Snapshot

ADVM Stock  USD 5.93  0.04  0.68%   
About 62% of all Adverum Biotechnologies' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Adverum Biotechnologies suggests that some traders are interested. Adverum Biotechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Adverum Biotechnologies. Many technical investors use Adverum Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
REDWOOD CITY, Calif. AP Adverum Biotechnologies Inc. ADVM on Thursday reported a loss of 32.7 million in its fourth quarter.

Read at finance.yahoo.com
Yahoo News
  

Adverum Biotechnologies Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Adverum Biotechnologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Adverum Biotechnologies Fundamental Analysis

We analyze Adverum Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adverum Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adverum Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Adverum Biotechnologies is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Adverum Biotechnologies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adverum Biotechnologies stock to make a market-neutral strategy. Peer analysis of Adverum Biotechnologies could also be used in its relative valuation, which is a method of valuing Adverum Biotechnologies by comparing valuation metrics with similar companies.

Peers

Adverum Biotechnologies Related Equities

ABSIAbsci Corp   8.96   
0%
55.0%
ACRVAcrivon Therapeutics,   8.02   
0%
49.0%
ANTXAN2 Therapeutics   2.65   
0%
16.0%
QUREUniqure NV   2.29   
0%
14.0%
RZLTRezolute   0.20   
1.0%
0%
MREOMereo BioPharma   0.26   
1.0%
0%
KZRKezar Life   0.72   
4.0%
0%
SLDBSolid Biosciences   0.79   
4.0%
0%
RYTMRhythm Pharmaceuticals   1.02   
6.0%
0%
RCKTRocket Pharmaceuticals   1.04   
6.0%
0%
AVTEAerovate Therapeutics   1.14   
7.0%
0%
MGTXMeiraGTx Holdings   1.76   
10.0%
0%
STOKStoke Therapeutics   2.11   
13.0%
0%
AFMDAffimed NV   2.59   
15.0%
0%
PASGPassage Bio   4.29   
26.0%
0%
GLMDGalmed Pharmaceuticals   5.57   
34.0%
0%
KODKodiak Sciences   10.60   
65.0%
0%
ADAGAdagene   16.21   
100.0%
0%
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Adverum Biotechnologies Hype Analysis, Adverum Biotechnologies Correlation and Adverum Biotechnologies Performance.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.95)
Revenue Per Share
0.059
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.30)
Return On Equity
(0.76)
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.